Comparison of Retinal Nerve Fiber Layer (RNFL) Thickness Measurements by Time-Domain and Spectral-Domain OCT In Glaucoma Patients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00773877|
Recruitment Status : Unknown
Verified October 2008 by Yonsei University.
Recruitment status was: Recruiting
First Posted : October 16, 2008
Last Update Posted : October 16, 2008
Measurement of RNFL thickness by OCT is at a cornerstone for the correct diagnosis and monitoring of progression of glaucomatous optic neuropathy.
Spectral domain technology has enabled better reproducibility with better axial resolution in the measurement of RNFL thickness. A comparative study among Stratus, Cirrus and RT-View will enable clinicians to determine differences among various instruments.
|Condition or disease|
|Primary Open Angle Glaucoma|
|Study Type :||Observational|
|Estimated Enrollment :||400 participants|
|Official Title:||Comparison of RNFL Thickness Measurements by Time-Domain and Spectral-Domain OCT In Glaucoma Patients|
|Study Start Date :||October 2008|
|Estimated Primary Completion Date :||December 2008|
|Estimated Study Completion Date :||December 2008|
Primary open angle glaucoma
- RNFL thickness [ Time Frame: 1 month ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00773877
|Contact: Chan Yun Kim, MD,PhDfirstname.lastname@example.org|
|Contact: Sung Yong Kang, MD||82-2-2228-3570|
|Korea, Republic of|
|Institute of Vision Research, Department of Ophthalmology, Severance Hospital, Yonsei University School of Medicine||Recruiting|
|Seoul, Korea, Republic of, 120-752|
|Contact: Chan Yun Kim, MD,PhD 82-2-2228-3570 email@example.com|
|Contact: Sung Yong Kang, MD 82-2-2228-3570 firstname.lastname@example.org|
|Principal Investigator: Chan Yun Kim, MD,PhD.|